Takeda Pharmaceutical’s Tokyo office. The Japanese firm has agreed to buy rival Shire for about £46 billion. Photo: EPA

Japan’s Takeda clinches US$62 billion deal to buy rival drug maker Shire

The deal would push the Japanese firm into the top 10 global drug firms as it searches for new growth

Topic |   Mergers & Acquisitions

TOP PICKS

Takeda Pharmaceutical’s Tokyo office. The Japanese firm has agreed to buy rival Shire for about £46 billion. Photo: EPA
READ FULL ARTICLE